This study included a group of fibromyalgia-diagnosed w0men taking a full course of 40 hyperbaric oxygen sessions at 1.45 ATA (90 minutes per session, 5 days per week, for a total of 8 weeks). Follow up results showed significant improvements in pain threshold <view study> Read Less

This 2021 review of literature suggest benefit for using hyperbaric oxygen therapy in ulcerative colitis flares and Crohn's disease <view study> Read Less

Atopic dermatitis (eczema) or AD is a condition that makes your skin red and itchy and is one of the most common inflammatory skin diseases in children. As the disease progresses in severity the consequences can be seen in sleeping disturbances, irritability, stress and social functioning disorders. After only a the 30-day treatment cycle in a hyperbaric chamber, all children with severe atopic dermatitis experienced a significant clinical improvement in their skin condition. There was a reduction in the extent and intensity of skin lesions, as well as a reduction of redness, swelling, oozing/crusting, scratch marks and skin lichenification. Moreover, patients reported a noticeable reduction in the intensity of pruritus (itching) and an improvement in sleep quality! These results are very promising and should give rise to more research into effective treatment dosages and protocols. This particular study used 2.5 ATA for 60 minutes (three 20 min sessions separated by two 5 minute air breaks).  <view study> Read Less

The benefits of hyperbaric oxygen therapy for dramatic brain injury (TBI) has been confirmed by many studies. Now the question is “what is the best dose (ie, pressure protocol) to achieve the optimal benefits. As new research becomes available, it appears that the lower the pressure, the stronger the benefits. This study confirms the recent data, by showing that 1.6 ATA hyperbaric intervention was superior to 2.2ATA for neurological impairment and the restoration of symptoms following TBI. Researchers in this study suggested that “for the first time that 1.6 ATA HBO has an important protective role in inhibiting both the cytotoxic and the pro-inflammatory actions of histones in the early stage of secondary brain injury”. <view study> Read Less

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint damage. Synovial hypoxia (low oxygen) is a specific feature of RA and plays an important role in the formation and progression of this disease. “Hypoxia induces angiogenesis, inflammation, apoptosis, cartilage erosion, abnormal energy metabolism and oxidative damage” Hyperbaric oxygen therapy (HBOT) can reverse hypoxic conditions throughout the body and therefore can help effectively halt the pathogenesis of RA. In this study, the animal model of RA was evaluated with hyperbaric oxygen therapy; whereby, male mice received a total of 10 daily hyperbaric sessions at 2.4 ATA (90 minutes of pure oxygen and two 5 minute air breaks). This group of mice that received HBOT had a significant reduction in the mouse model of arthritis, along with the reduction in disease-progressive inflammatory markers. After evaluating all the data collected from this study, the researchers concluded that a 10 day course of hyperbaric therapy in 12 days can be “an alternative therapy that is considered successful in reducing morbidity and mortality of RA patients” <view study> In addition to the study above, a new pilot study published in the journal of Clinical Rheumatology on September 16, 2020 also found Hyperbaric oxygen therapy to be effective for joint pain in patients with RA <view this study> Read Less